[1] |
Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection[J]. Lancet, 1993, 341(8844):515-518.
|
[2] |
van Engelen TSR, Wiersinga WJ, Scicluna BP, et al. Biomarkers in sepsis[J]. Crit Care Clin, 2018, 34(1):139-152.
|
[3] |
Ahmed AI, Soliman RA, Samir S. Cell Free DNA and Procalcitonin as Early Markers of Complications in ICU Patients with Multiple Trauma and Major Surgery[J]. Clin Lab, 2016, 62(12):2395-2404.
|
[4] |
Hoshino K, Irie Y, Mizunuma M, et al. Incidence of elevated procalcitonin and presepsin levels after severe trauma: a pilot cohort study[J]. Anaesth Intensive Care, 2017, 45(5):600-604.
|
[5] |
Meisner M, Tschaikowsky K, Hutzler A, et al. Postoperative plasma concentrations of procalcitonin after different types of surgery[J]. Intensive Care Med, 1998, 24(7):680-684.
|
[6] |
Cabral L, Afreixo V, Santos F, et al. Procalcitonin for the early diagnosis of sepsis in burn patients: A retrospective study[J]. Burns, 2017, 43(7):1427-1434.
|
[7] |
Wineberg DL, Kruger D. The role of procalcitonin as a diagnostic marker of bacterial sepsis in burns[J]. S Afr J Surg, 2017, 55(2):76.
|
[8] |
Sandkovsky U, Kalil AC, Florescu DF. The use and value of procalcitonin in solid organ transplantation[J]. Clin Transplant, 2015, 29(8):689-696.
|
[9] |
Annborn M, Dankiewicz J, Erlinge D, et al. Procalcitonin after cardiac arrest- an indicator of severity of illness, ischemia-reperfusion injury and outcome[J]. Resuscitation, 2013, 84(6):782-787.
|
[10] |
Sternby H, Hartman H, Johansen D, et al. Predictive capacity of biomarkers for severe acute pancreatitis[J]. Eur Surg Res, 2016, 56(3/4):154-163.
|
[11] |
Muroi C, Lemb JB, Hugelshofer M, et al. Early systemic procalcitonin levels in patients with aneurysmal subarachnoid hemorrhage[J]. Neurocrit Care, 2014, 21(1):73-77.
|
[12] |
Cheng W, Yan-hua R, Fang-gang N, et al. Epidemiology of 1974 burn patients at a major burn center in Beijing: a nine-year study[J]. J Burn Care Res, 2012, 33(5):e228-233.
|
[13] |
Yao Y, Liu Y, Zhou J, et al. The epidemiology of civilian inpatients′ burns in Chinese military hospitals, 2001-2007[J]. Burns, 2011, 37(6):1023-1032.
|
[14] |
徐风瑞,乔亮,韩伟,等. 大面积烧伤并发脓毒症的独立危险因素[J]. 中华创伤杂志,2016, 32(3):237-240.
|
[15] |
Pan C, Cui W, Zhou F, et al. Clinical characteristics and prognosis in patients with high plasma level of procalcitonin: an analysis in 188 patients[J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2017, 29(7):613-618.
|
[16] |
刘兆兴,申传安. 血清降钙素原在烧伤脓毒症诊断治疗中的应用价值[J/CD]. 中华损伤与修复杂志(电子版), 2016, 11(5):386-389.
|
[17] |
Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses[J]. Nat Rev Immunol, 2004, 4(6):469-478.
|
[18] |
Evavold CL, Kagan JC. How Inflammasomes Inform Adaptive Immunity[J]. J Mol Biol, 2018, 430(2):217-237.
|
[19] |
宋秀琴,时兢,俞娅芬,等. 创伤患者血浆降钙素原检测的临床意义[J]. 中华创伤杂志,2005, 21(4):275.
|
[20] |
郇京宁. 烧伤休克液体复苏研究进展[J]. 中华烧伤杂志,2013, 29(3):285-288.
|
[21] |
Rae L, Fidler P, Gibran N. The physiologic basis of burn shock and the need for aggressive fluid resuscitation[J]. Crit Care Clin, 2016, 32(4):491-505.
|
[22] |
Cartotto R, Greenhalgh DG, Cancio C. Burn state of the science: fluid resuscitation[J]. J Burn Care Res, 2017, 38(3):e596-604.
|
[23] |
Porter C, Tompkins RG, Finnerty CC, et al. The metabolic stress response to burn trauma: current understanding and therapies[J]. Lancet, 2016, 388(10052):1417-1426.
|
[24] |
Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure[J]. Intensive Care Med, 1996, 22(7):707-710.
|
[25] |
Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system[J]. Crit Care Med, 1985, 13(10):818.
|
[26] |
Kim HS, Yang HT, Hur J, et al. Procalcitonin levels within 48 hours after burn injury as a prognostic factor[J]. Ann Clin Lab Sci, 2012, 42(1):57-64.
|